Skip to main content
. 2017 Sep 14;23(34):6294–6305. doi: 10.3748/wjg.v23.i34.6294

Figure 1.

Figure 1

Associations between availability, affordability, gross domestic product per capita and the uptake of biosimilars. Cz: The Czech Republic; Fr: France; D: Germany; Hu: Hungary; Lv: Latvia; Pl: Poland; Ro: Romania; Sk: Slovakia; Es: Spain; Se: Sweden; Prevalence: Patients on biologicals per 100000 population. GDP: Gross domestic product.